Tonsillar Abscess Treatment Guidelines

Introduction to Antibiotic Therapy

The American College of Physicians recommends Clindamycin as the best initial antibiotic for a patient with a tonsillar abscess, typically administered at 600-900 mg IV every 8 hours for hospitalized patients or 300-450 mg PO every 6 hours for outpatients 1
Clindamycin provides excellent coverage against both aerobic gram-positive organisms and anaerobic bacteria commonly found in peritonsillar abscesses, with good tissue penetration in the tonsillar region 1

For adults with tonsillar abscess, Clindamycin is recommended at 600-900 mg IV every 8 hours (hospitalized) or 300-450 mg PO every 6 hours (outpatient) 1
For MRSA concerns, Vancomycin is recommended at 15 mg/kg IV every 12 hours, and Linezolid at 600 mg PO/IV twice daily 2

7-14 days of antibiotic therapy is recommended for tonsillar abscess treatment 1
Treatment should be individualized based on clinical response, and consideration of MRSA coverage is necessary in certain cases, such as prior MRSA infection, recent antibiotic exposure, or local high prevalence of MRSA 2

For patients with penicillin allergy, Clindamycin remains an excellent first choice, and alternative options include respiratory fluoroquinolones (in adults only) 3

Patients with tonsillar abscess should be monitored for airway compromise, extension of infection into deep neck tissues, and inadequate drainage requiring repeat aspiration or surgical intervention, as well as Clindamycin-associated C. difficile colitis 1